trial
as of 2026-07-01Risk of Breakthrough Symptoms With Long-Acting Injectable Medications
NCTId NCT05473741
at a glance
Phase — · Completed
Enrollment 51 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2025-10-27
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
51 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2023-01-11
Primary completion
2025-10-27
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Investigators
1
Robert B Zipursky, MDPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
51
Phase
NA
Primary Completion Date
2025-10-27
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
collaborator
indication
investigator
person